Directly acting antiviral HCV therapy is safe and effective in patients with advanced cirrhosis: real world experience from the HCV-TARGET Cohort

Authors :: Giuseppe Morelli
S. Zeuzem
Rajender Reddy
G. Lutchman
M. Hassan
Michael Fried
Monika Vainorius
Joseph K. Lim
Norah A. Terrault
Charles S. Landis
David R. Nelson
Lucy Akushevich
M.P. Manns
A. M. Di Bisceglie
Elizabeth C. Verna
Anna S.F. Lok
Source :: Journal of Hepatology. 68:S19-S20
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: medicine.medical_specialty
Hepatology
business.industry
Advanced cirrhosis
Internal medicine
Cohort
medicine
Hcv therapy
In patient
business

Full Text Access

Tools